{"id":"NCT04542057","sponsor":"Verona Pharma plc","briefTitle":"A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD","officialTitle":"A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-22","primaryCompletion":"2022-05-03","completion":"2022-07-06","firstPosted":"2020-09-09","resultsPosted":"2023-07-24","lastUpdate":"2023-10-16"},"enrollment":790,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"Ensifentrine","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"},{"label":"Arm 2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if ensifentrine is safe and effective for the treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).","primaryOutcome":{"measure":"Least Square (LS) Mean Change From Baseline in Average Forced Expiratory Volume in 1 Second (FEV1) Area Under the Curve Over 12 Hours (AUC0-12h) at Week 12","timeFrame":"Baseline (40 minutes before first administration on Day 1) and Week 12","effectByArm":[{"arm":"Ensifentrine","deltaMin":0.048,"sd":0.00941},{"arm":"Placebo","deltaMin":-0.0462,"sd":0.01236}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":130,"countries":["United States","Belgium","Bulgaria","Canada","Denmark","Estonia","Hungary","Poland","Slovakia","Spain"]},"refs":{"pmids":["39854278","39197510","39106052","37364283"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":28,"n":498},"commonTop":["COVID-19","Headache","Back pain","Urinary tract infection","Nasopharyngitis"]}}